Multiple Myeloma Stocks List

Recent Signals

Date Stock Signal Type
2019-11-20 ADAP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-20 ADAP Pocket Pivot Bullish Swing Setup
2019-11-20 ADAP 20 DMA Resistance Bearish
2019-11-20 ADAP 1,2,3 Retracement Bearish Bearish Swing Setup
2019-11-20 BMY 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-20 BMY Volume Surge Other
2019-11-20 BMY Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-20 BMY Hammer Candlestick Bullish
2019-11-20 CALA Upper Bollinger Band Walk Strength
2019-11-20 CALA Pocket Pivot Bullish Swing Setup
2019-11-20 CASI Shooting Star Candlestick Bearish
2019-11-20 CASI 20 DMA Support Bullish
2019-11-20 CASI Cup with Handle Other
2019-11-20 CASI Lizard Bearish Bearish Day Trade Setup
2019-11-20 CASI Doji - Bearish? Reversal
2019-11-20 CASI 50 DMA Support Bullish
2019-11-20 CLLS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-20 CLLS 20 DMA Support Bullish
2019-11-20 CLLS 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-20 CNST New 52 Week Closing High Bullish
2019-11-20 GMAB MACD Bearish Signal Line Cross Bearish
2019-11-20 GMAB Bollinger Band Squeeze Range Contraction
2019-11-20 HARP Volume Surge Other
2019-11-20 HARP Upper Bollinger Band Walk Strength
2019-11-20 LGND MACD Bearish Centerline Cross Bearish
2019-11-20 LGND Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-20 LGND Crossed Above 50 DMA Bullish
2019-11-20 XOMA Spinning Top Other
2019-11-20 XOMA Slingshot Bullish Bullish Swing Setup
2019-11-20 XTLB New 52 Week Low Weakness
2019-11-20 XTLB Stochastic Reached Oversold Weakness
2019-11-20 XTLB New 52 Week Closing Low Bearish

Multiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. Often, no symptoms are noticed initially. When advanced, bone pain, bleeding, frequent infections, and anemia may occur. Complications may include amyloidosis.The cause is unknown. Risk factors include obesity, radiation exposure, family history, and certain chemicals. The underlying mechanism involves abnormal plasma cells producing abnormal antibodies which can cause kidney problems and overly thick blood. The plasma cells can also form a mass in the bone marrow or soft tissue. When only one mass is present, it is known as a plasmacytoma, while more than one is known as multiple myeloma. Multiple myeloma is diagnosed based on blood or urine tests finding abnormal antibodies, bone marrow biopsy finding cancerous plasma cells, and medical imaging finding bone lesions. Another common finding is high blood calcium levels.Multiple myeloma is considered treatable, but generally incurable. Remissions may be brought about with steroids, chemotherapy, targeted therapy, and stem cell transplant. Bisphosphonates and radiation therapy are sometimes used to reduce pain from bone lesions.Globally, multiple myeloma affected 488,000 people and resulted in 101,100 deaths in 2015. In the United States, it develops in 6.5 per 100,000 people per year and 0.7% of people are affected at some point in their lives. It usually occurs around the age of 61 and is more common in men than women. It is uncommon before the age of 40. Without treatment, typical survival is seven months. With current treatments, survival is usually 4–5 years. This gives a five-year survival rate around 49%. The word myeloma is from the Greek myelo- meaning "marrow" and -oma meaning "tumor".

More about Multiple Myeloma